Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. - Test2 - elhamkhani - TriplyDB

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

http://www.wikidata.org/entity/Q28943325

about

Behavioral variant frontotemporal lobar degeneration with amyotrophic lateral sclerosis with a chromosome 9p21 hexanucleotide repeat Menopause, obesity and inflammation: interactive risk factors for Alzheimer's disease TREM2 Variants in Alzheimer's Disease Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a community setting APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a secondary care setting APOE -ε4 allele for the diagnosis of Alzheimer's and other dementia disorders in people with mild cognitive impairment in a primary care setting The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data Analysis of copy number variation in Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals SORLA-dependent and -independent functions for PACS1 in control of amyloidogenic processes Lysosomal sorting of amyloid-β by the SORLA receptor is impaired by a familial Alzheimer's disease mutation Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play Exocyst complex component 3-like 2 (EXOC3L2) associates with the exocyst complex and mediates directional migration of endothelial cells ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models Targeting innate immunity for neurodegenerative disorders of the central nervous system Modeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future Concerns Emerging Genomic Tools for Legume Breeding: Current Status and Future Prospects Genes associated with Alzheimer's disease: an overview and current status Toward precision medicine in Alzheimer's disease Toward precision medicine in neurological diseases Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies Alzheimer's Disease: Mechanism and Approach to Cell Therapy Genetics ignite focus on microglial inflammation in Alzheimer's disease TREM2 in CNS homeostasis and neurodegenerative disease The genetic landscape of Alzheimer disease: clinical implications and perspectives Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014 Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkers The low-density lipoprotein receptor-related protein 1 and amyloid-β clearance in Alzheimer's disease Alzheimer's disease: new data highlight nonneuronal cell types and the necessity for presymptomatic prevention strategies Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease Rodent models of neuroinflammation for Alzheimer's disease Epidemiology of Alzheimer disease Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals The genetics and neuropathology of Alzheimer's disease The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception The search for longevity and healthy aging genes: insights from epidemiological studies and samples of long-lived individuals

P2860

04881035c65073bd393179dc5ef42c6824900856

P248

Q21129431-9BDA857E-DDC2-4046-B9FA-6E0B7DCA9242 Q21131065-9AA1EB40-2DFF-441C-8134-AAC9BEF4B96F Q22250873-F2820969-C572-4559-B9EA-D5D53DAEDC35 Q22251067-425792CB-3214-486D-85D5-0699FCE5FF54 Q24201260-B7FF4DBF-13EE-4929-B090-46313F270C8B Q24201265-FC13B9F3-1D58-44C5-81A2-6B39EE048F2F Q24201271-63ED573C-020C-45F9-A5E3-1DCF978E696E Q24289484-CB084227-5517-4357-8243-B57D130EF9EB Q24305513-26A6D90D-4791-4C24-BF3F-229759AC10BF Q24322095-FE2804FC-8B23-4E81-9EA9-FB48E693F6FC Q24337087-4A51DB74-10D2-47F3-B779-EC8F5EB996F1 Q24338543-3AC0AFA0-DA90-41D3-A379-C5D113D04A13 Q24594531-607270A0-6D7E-47E6-9AD2-BEB9E1EE6814 Q24598553-0D52A4F3-B565-425F-B2C7-6C9BA410E03B Q24628845-8B0EC09D-1C8C-4E0C-9B4A-FF1A74A49D60 Q26744219-4D7DD97A-3B79-4DA6-AF35-E0C9ACFCE3AA Q26745513-AC251391-33F3-4111-B72F-A86C9A2A800F Q26747385-D55216AB-6BB2-4752-9534-EE29304EE7BC Q26747803-F24F8CA1-5A28-47F3-9E8C-6AC7B6FA9988 Q26748939-8150EEB0-DE1A-4CE9-BD07-076B891561BB Q26748951-6D67E64A-264E-407A-A7CD-78764340B372 Q26767289-2E427F72-41C4-48DD-AD47-05F83C72CBAC Q26769957-C80E3DFD-673E-42C1-874E-1BAEF7A6F280 Q26778149-33EB850C-CE4B-4B55-A713-A45B0AF84390 Q26781865-E36627D0-22E9-4303-8F94-B0B53E8082F8 Q26785919-D7B8C046-CFDB-4DCA-8453-BCCAF425E5A9 Q26796582-F6A6DD0B-C94B-4AC0-B12C-B07470E9DFA1 Q26799870-59E01EED-2D9C-43B7-82FF-ABA5E45B8F05 Q26801629-A083540E-9CBA-4B87-A80C-B950AAB9C9A8 Q26801647-26DE824E-54E6-408D-B531-CD21D703514A Q26825442-E9459981-C151-40ED-B317-CB7C9AE84319 Q26827353-7850DE85-FDF3-4326-8E83-96C2D3B90D8F Q26852851-BEB1F569-67D7-43B5-A95B-9526D500C15A Q26853610-BBCD8499-4A11-4BF1-AA88-07902C5903B1 Q26864804-DC531012-3E7E-4B40-8009-DD6E038E0A94 Q26865371-CDF5E87C-30C6-4367-B1EF-C2D244697822 Q26995405-4164CC0D-B05A-40CD-A2E8-13A1B49DE540 Q26998097-24E3ADE4-4154-4CD2-9F0B-0317CF71139A Q27006831-B069AD01-252D-4B15-B823-B793E4B2D065 Q27013823-36DD6C6F-6369-4F55-A03B-E2D7E3D4E875

P2860

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

http://www.wikidata.org/entity/Q28943325

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@ast

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@bar

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@de

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@en

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@fr

type

label

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@ast

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@bar

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@de

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@en

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@fr

prefLabel

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@ast

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@bar

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@de

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@en

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@fr

P1433

Q28943325-5A84BFEC-B8A5-4BBE-9666-883802527439

P1476

Q28943325-D4B641B4-B69C-4ED0-A426-54E1365BC066

P2093

Q28943325-01A6FA32-B7D3-4BB4-91FB-F2DDBD080401

Q28943325-02ADE150-1658-474A-96B0-6E6992ADCBE3

Q28943325-04CF7932-4130-45C8-9E32-6199E282E397

Q28943325-0738F95B-B72F-487F-8EFE-4B09113CCAD4

Q28943325-0A1A460A-6B0C-4230-AD8D-D8BC88CFB73C

Q28943325-0CBECEE4-10B3-4757-A2B8-3A2204A09714

Q28943325-101B324E-CF5E-44B9-B08E-7752801978CB

Q28943325-1120BA64-6BF5-47FB-9C15-336A7AA26626

Q28943325-1480D52C-9080-436B-B453-730F5C1306F7

Q28943325-184E1E27-EE0A-4F6C-894D-2B92704D602D

P2860

Q28943325-1D176F1F-1240-4B3E-BF13-D72549E1D369

Q28943325-1EFB2594-CB56-40CF-975A-7C95A29BB4C7

Q28943325-1FD51D2D-02D8-475E-B013-749063953AF2

Q28943325-2930694D-2DC4-42AF-890E-7CA74BA0E05B

Q28943325-30FCDEF0-99E6-4F4C-A208-207DF7333C06

Q28943325-3AFA6233-7C49-4C23-ABB3-3EDEF8DDE442

Q28943325-447960B8-A545-40B7-887C-5F90C44A7086

Q28943325-457F89B2-3357-41DC-AFC8-ED5191BCECF8

Q28943325-573E9E5B-551D-4395-A936-14E4B08449C6

Q28943325-684A3602-FFB7-4E8F-8430-6C3A422760A0

P2888

Q28943325-6537C486-A56C-4F69-92FC-F36478DAC5FA

P304

Q28943325-B7D288DB-FBE6-48F6-9508-3C0AC7317615

P31

Q28943325-91372D3D-9B6F-4A0C-9740-8A3E461DCFB4

Q28943325-de450533-e94d-4ff2-9c3b-d663aab02b86

P3181

Q28943325-2B924301-C042-4F94-BB60-81B69F85C204

P356

Q28943325-7B8AD4F0-1E72-4377-AC9C-7533B30D2763

P407

Q28943325-BD27ADBE-9C5C-45DC-A041-AF9E52796A80

P433

Q28943325-E6626917-7C52-40BD-8B28-AAB99E468A34

P478

Q28943325-ED162E7A-07BC-4740-8411-E49DA59CE385

P50

Q28943325-00B99FBE-C3DA-4335-BFF1-73FCBC1136B0

Q28943325-024076B1-B1B7-48A9-AA87-E98CB7E04A21

Q28943325-0438CC4E-6B16-4395-B12F-7EB96AE039E9

Q28943325-06073FCD-79E9-4889-BAC2-15A2CAC442E3

Q28943325-0DC89AC9-4DE3-4AB9-8A49-BAD55CEC7F89

Q28943325-130CCAB4-EFCB-4409-80B0-1500305150E7

Q28943325-13913101-7E0B-4A37-8128-EBAA154583EA

Q28943325-15B705C1-F252-4477-B16C-DCD3D2952C99

Q28943325-17C63F42-F818-4BC2-948C-EBA0EC56895F

Q28943325-1863CB4A-D919-4F1D-919A-7FCDE5244BC7

P577

Q28943325-CF2C6FE8-F7D8-49B5-A7AD-115BBAC89350

P5875

Q28943325-DA92AD3B-D0A9-4044-843A-57FAE5AD786F

P698

Q28943325-EFF92619-9EFA-4EB3-8D89-1352408654F3

P921

Q28943325-F606F395-8047-4CC9-B7C6-93534BD0752F

P932

Q28943325-87103429-ECB6-4327-A243-E1F5F085FC42

P3181

P356

P1433

Nature Genetics

P1476

Common variants at MS4A4/MS4A6 ...... ate-onset Alzheimer's disease.

@en

P2093

Adam C Naj

http://www.w3.org/2001/XMLSchema#string

Allan I Levey

http://www.w3.org/2001/XMLSchema#string

Amanda J Myers

http://www.w3.org/2001/XMLSchema#string

Andrew P Lieberman

http://www.w3.org/2001/XMLSchema#string

Ann C McKee

http://www.w3.org/2001/XMLSchema#string

Anna Karydas

http://www.w3.org/2001/XMLSchema#string

Badri Narayan Vardarajan

http://www.w3.org/2001/XMLSchema#string

Bernardino Ghetti

http://www.w3.org/2001/XMLSchema#string

Beth A Dombroski

http://www.w3.org/2001/XMLSchema#string

Bradley F Boeve

http://www.w3.org/2001/XMLSchema#string

P2860

Alzheimer Disease in the US Population

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Handling marker-marker linkage disequilibrium: pedigree analysis with clustered markers

Inference of population structure using multilocus genotype data

Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease

GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers

The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease

PLINK: a tool set for whole-genome association and population-based linkage analyses

Measuring inconsistency in meta-analyses

P2888

P304

436-441

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

274565

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.801

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Rudolph E. Tanzi

Daniel Geschwind

Eliezer Masliah

Charles DeCarli

Margaret A. Pericak-Vance

Hakon Hakonarson

Ekaterina Rogaeva

Nilüfer Ertekin-Taner

P577

2011-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50989718

http://www.w3.org/2001/XMLSchema#string

P698

21460841

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

3090745

http://www.w3.org/2001/XMLSchema#string